Targeting Doublecortin-like Kinase 1 (DCLK1) in Colon Cancer: An <it>In</it>-<it>silico</it> Approach

被引：0
|
作者：
Parsai, Janhvi [1 ]
Crockett, Cooper [1 ]
Kimball, Hunter [1 ]
Raval, Nipam [1 ]
机构：
[1] Olathe North High Sch, Olathe, KS USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.05754
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Enhanced Expression of Doublecortin-Like Kinase 1 (DCLK1) in the Background Mucosa of Colon Cancer
    Hirata, Yuki
    Sezaki, Takuhito
    Hagiwara, Teruki
    Edogawa, Shoko
    Okada, Toshihiko
    Inoue, Takuya
    Yano, Hideaki
    Gohda, Yoshimasa
    Suda, Ryuichiro
    Hirose, Yoshinobu
    Kawamura, Yutaka J.
    Higuchi, Kazuhide
    Dohi, Taeko
    Kawamura, Yuki I.
    GASTROENTEROLOGY, 2015, 148 (04) : S572 - S572
  • [2] Doublecortin-like Kinase 1 (DCLK1) correlates with the cell proliferation in malignant pleural mesothelioma
    Miura, Akihiro
    Yamamoto, Hiromasa
    Tao, Hiroyuki
    Suzawa, Ken
    Miyauchi, Syunsaku
    Araki, Kota
    Takahashi, Yuta
    Kurihara, Eisuke
    Ogoshi, Yusuke
    Shien, Kazuhiko
    Soh, Junichi
    Okabe, Kazunori
    Tomida, Shuta
    Sakaguchi, Masakiyo
    Toyooka, Shinichi
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Doublecortin-like kinase 1 (DCLK1) is novel Notch pathway signaling regulator in HNSCC
    Broner, Esther Channah
    Subbannayya, Tejaswini
    Zhavoronkov, Alex
    Korzinkin, Mike
    Artemov, Artem
    Ozerov, Ivan
    Sloma, Ido
    Sidransky, David
    Chatterjee, Aditi
    Izumchenko, Evgeny
    CANCER RESEARCH, 2019, 79 (13)
  • [4] First-in-class Doublecortin-like kinase 1 (DCLK1) inhibitor for targeting cancer stem cell in hepatocellular carcinoma.
    Yoon, Daseul
    Jung, Seung Hee
    Jang, Ju Young
    Ahn, Ji-Young
    Jo, Seung Jin
    Ko, Donghyun
    Kim, Dong-kyu
    Yu, Su Jong
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
    Undi, Ram Babu
    Larabee, Jason L.
    Filiberti, Adrian
    Ulahannan, Susanna
    Aravindan, Sheeja
    Stroberg, Edana
    Barton, Lisa M.
    Duval, Eric J.
    Mukhopadhyay, Sanjay
    Henthorn, James C.
    Akins, Darrin
    Houchen, Courtney W.
    Huycke, Mark M.
    Ali, Naushad
    JOURNAL OF VIROLOGY, 2022, 96 (17)
  • [6] Doublecortin-like kinase 1 (DCLK1) and NOTCH1 pathways lead to poor prognosis in HNSCC
    Broner, Esther Channah
    Rooper, Lisa
    Subbannayya, Tejaswini
    Chatterjee, Aditi
    Sidransky, David
    Izumchenko, Evgeny
    CANCER RESEARCH, 2020, 80 (16)
  • [7] ROLE OF DOUBLECORTIN-LIKE KINASE 1 (DCLK1) POSITIVE TUFT CELLS IN COLITIS-ASSOCIATED COLORECTAL CANCER
    Shin, Alice E.
    Fazio, Elena N.
    Zhang, Liyue
    Good, Hayley
    Sherman, Philip M.
    Wang, Timothy C.
    Asfaha, Samuel
    GASTROENTEROLOGY, 2018, 154 (06) : S23 - S23
  • [8] Doublecortin-like kinase 1 (DCLK1) correlates with Notch pathway signaling, controls metastatic characteristics in head and neck cancer
    Broner, Esther Channah
    Subbannayya, Tejaswini
    Advani, Jayshree
    Zhavoronkov, Alex
    Artemov, Artem
    Ozerov, Ivan
    Sloma, Ido
    Gowda, Harsha
    Sidransky, David
    Izumchenko, Eugene
    Chatterjee, Aditi
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects
    Nevi, L.
    Di Matteo, S.
    Carpino, G.
    Cardinale, V.
    Zizzari, I.
    Ambrosino, V.
    Costantini, D.
    Safarikia, S.
    Manzi, E.
    Derose, A. M.
    Melandro, F.
    Bragazzi, M. C.
    Grazi, G.
    Berloco, P. B.
    Giuliante, F.
    Gaudio, E.
    Alvaro, D.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 5 - 6
  • [10] A putative stem cell marker, doublecortin-like kinase (DCLK1), is involved in the development of hepatocellular carcinoma
    Ali, Naushad
    CANCER RESEARCH, 2013, 73 (08)
12345